Literature DB >> 10980137

Topographical distributions of allelic loss in individual non-small-cell lung cancers.

Y Yatabe1, H Konishi, T Mitsudomi, S Nakamura, T Takahashi.   

Abstract

Non-small-cell carcinomas of the lung, especially adenocarcinomas, are characterized by a high degree of morphological heterogeneity. As carcinogenesis has been suggested to be a multistep process involving sequential accumulation of multiple genetic alterations, morphological heterogeneity may represent a cross-sectional view of genetic alterations within individual tumors. We therefore examined the topographical distribution of loss of heterozygosity (LOH) events within 10 non-small-cell lung cancers to investigate whether, and which, genetic alterations are accumulated in relation to morphological progression. LOH at the TP53, 17p13.3, and 3p loci was detected in six, eight, and six of 10 informative cases, respectively. In each case, all portions of the tumor shared concordant LOH despite morphological diversity. In contrast, distributions of LOH at 2q, 9p, and 22q, which have been reported to be associated with the advanced stages of tumors, were divergent in two of three, four of eight, and one of one cases with LOH, respectively. In these cases, presence of LOH was mostly related to the morphological tumor grades. These findings suggest the accumulative feature of genetic alterations in particular loci that can be seen even in individual tumors. Furthermore, the present study indicated that cross-sectional examination of individual tumors is also important for better understanding of molecular pathogenesis of lung cancers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980137      PMCID: PMC1885713          DOI: 10.1016/S0002-9440(10)64611-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas.

Authors:  B R Balsara; G Sonoda; S du Manoir; J M Siegfried; E Gabrielson; J R Testa
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

2.  Detection of c-Ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchioloalveolar cell hyperplasia of human lung.

Authors:  S Ohshima; Y Shimizu; M Takahama
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Comparative allelotype of early and advanced stage non-small cell lung carcinomas.

Authors:  M Shiseki; T Kohno; J Adachi; T Okazaki; T Otsuka; H Mizoguchi; M Noguchi; S Hirohashi; J Yokota
Journal:  Genes Chromosomes Cancer       Date:  1996-10       Impact factor: 5.006

4.  Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.

Authors:  M Shiseki; T Kohno; R Nishikawa; Y Sameshima; H Mizoguchi; J Yokota
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

5.  Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression.

Authors:  C R Boland; J Sato; H D Appelman; R S Bresalier; A P Feinberg
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

6.  Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.

Authors:  J Hung; Y Kishimoto; K Sugio; A Virmani; D D McIntire; J D Minna; A F Gazdar
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

7.  Clonal evolution of lung tumors.

Authors:  G T Chung; V Sundaresan; P Hasleton; R Rudd; R Taylor; P H Rabbitts
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

8.  Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.

Authors:  M Nishio; T Koshikawa; T Kuroishi; M Suyama; K Uchida; Y Takagi; O Washimi; T Sugiura; Y Ariyoshi; T Takahashi; R Ueda; T Takahashi
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

9.  Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.

Authors:  Y Kishimoto; K Sugio; J Y Hung; A K Virmani; D D McIntire; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

10.  Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.

Authors:  J K Field; E M Neville; M P Stewart; A Swift; T Liloglou; J M Risk; H Ross; J R Gosney; R J Donnelly
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more
  2 in total

1.  Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.

Authors:  Giuseppe Pelosi; Alessio Pellegrinelli; Alessandra Fabbri; Elena Tamborini; Federica Perrone; Giulio Settanni; Adele Busico; Benedetta Picciani; Maria Adele Testi; Lucia Militti; Patrick Maisonneuve; Barbara Valeri; Angelica Sonzogni; Claudia Proto; Marina Garassino; Filippo De Braud; Ugo Pastorino
Journal:  Virchows Arch       Date:  2016-04-07       Impact factor: 4.064

2.  Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma.

Authors:  H Iijima; Y Tomizawa; K Dobashi; R Saito; T Nakajima; M Mori
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.